Čájehuvvojit 1 - 6 oktiibuot 6 bohtosis ohcui on behalf of the Collaborative Group', ohcanáigi: 0,03s Aiddostahte ozu
  1. 1
    Cellular Immune Response to BNT162b2 mRNA COVID-19 Vaccine in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital

    Cellular Immune Response to BNT162b2 mRNA COVID-19 Vaccine in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital Dahkki Cristina Costa, Gitana Scozzari, Enrica Migliore, Claudia Galassi, Giovannino Ciccone, Guido Ricciardelli, Antonio Scarmozzino, Lorenzo Angelone, Paola Cassoni, Rossana Cavallo, on behalf of the Collaborative Group

    Almmustuhtton 2022-06-01
    Viečča ollesdeavstta
    Artihkal
  2. 2
    Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers

    Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers Dahkki Cristina Costa, Enrica Migliore, Claudia Galassi, Gitana Scozzari, Giovannino Ciccone, Maurizio Coggiola, Enrico Pira, Antonio Scarmozzino, Giovanni La Valle, Paola Cassoni, Rossana Cavallo, on behalf of the Collaborative Group

    Almmustuhtton 2022-03-01
    Viečča ollesdeavstta
    Artihkal
  3. 3
    Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients’ risk level

    Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients’ risk level Dahkki Daria Roccatagliata, Fausto Avanzini, Lara Monesi, Vittorio Caimi, Davide Lauri, Paolo Longoni, Roberto Marchioli, Massimo Tombesi, Gianni Tognoni, Maria Carla Roncaglioni, on behalf of the Collaborative Group Risk, Prevention Study

    Almmustuhtton 2006-12-01
    Viečča ollesdeavstta
    Artihkal
  4. 4
    How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for RUNX1 variant curation for germline predisposition to myeloid malignancies

    How I curate: applying American Society of Hematology-Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel rules for RUNX1 variant curation for germline predis... Dahkki David Wu, Xi Luo, Simone Feurstein, Chimene Kesserwan, Shruthi Mohan, Daniel E. Pineda-Alvarez, Lucy A. Godley, on behalf of the collaborative group of the American Society of Hematology - Clinical Genome Resource Myeloid Malignancy Variant Curation Expert Panel

    Almmustuhtton 2020-04-01
    Viečča ollesdeavstta
    Artihkal
  5. 5
    CRADLE-5: a stepped-wedge type 2 hybrid implementation-effectiveness cluster randomised controlled trial to evaluate the real-world scale-up of the CRADLE Vital Signs Alert intervention into routine maternity care in Sierra Leone—study protocol

    CRADLE-5: a stepped-wedge type 2 hybrid implementation-effectiveness cluster randomised controlled trial to evaluate the real-world scale-up of the CRADLE Vital Signs Alert interve... Dahkki Alexandra E. Ridout, Francis L. Moses, Simren Herm-Singh, Cristina Fernandez Turienzo, Paul T. Seed, Venetia Goodhart, Nicola Vousden, Betty Sam, Mariama Momoh, Daniel Kamara, Katy Kuhrt, Sorie Samura, Candace Beoku-Betts, Alice Hurrell, Kate Bramham, Sartie Kenneh, Francis Smart, Lucy Chappell, Jane Sandall, Andrew Shennan, on behalf of CRIBS Collaborative Group

    Almmustuhtton 2023-09-01
    Viečča ollesdeavstta
    Artihkal
  6. 6
    Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis

    Impact of synthetic and biological immunomodulatory therapy on the duration of 17DD yellow fever vaccine-induced immunity in rheumatoid arthritis Dahkki Clarissa de Castro Ferreira, Ana Carolina Campi-Azevedo, Vanessa Peruhype-Magalhāes, Jordana Grazziela Coelho-dos-Reis, Lis Ribeiro do Valle Antonelli, Karen Torres, Larissa Chaves Freire, Ismael Artur da Costa-Rocha, Ana Cristina Vanderley Oliveira, Maria de Lourdes de Sousa Maia, Sheila Maria Barbosa de Lima, Carla Magda Domingues, Andréa Teixeira-Carvalho, Olindo Assis Martins-Filho, Lícia Maria Henrique da Mota, on behalf of the Collaborative Group for Studies of Yellow Fever Vaccine

    Almmustuhtton 2019-03-01
    Viečča ollesdeavstta
    Artihkal

Ohcanreaiddut: